Elevance Health
ELV
1,589 hedge funds and large institutions have $79.7B invested in Elevance Health in 2025 Q2 according to their latest regulatory filings, with 142 funds opening new positions, 598 increasing their positions, 607 reducing their positions, and 188 closing their positions.
43% more call options, than puts
Call options by funds: $706M | Put options by funds: $495M
0.96% more ownership
Funds ownership: 89.82% → 90.78% (+0.96%)
1% less repeat investments, than reductions
Existing positions increased: 598 | Existing positions reduced: 607
4% less funds holding
Funds holding: 1,660 → 1,589 (-71)
10% less capital invested
Capital invested by funds: $88.7B → $79.7B (-$9.07B)
24% less first-time investments, than exits
New positions opened: 142 | Existing positions closed: 188
26% less funds holding in top 10
Funds holding in top 10: 43 → 32 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$589M |
| 2 |
Sanders Capital
West Palm Beach,
Florida
|
+$464M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$375M |
| 4 |
BGC
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
+$303M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$283M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$563M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$425M |
| 3 |
BlackRock
New York
|
-$361M |
| 4 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$277M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$200M |
ELV Hedge Fund Activity: Q2 2025 in Review
1,589 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2025, worth a combined $79.7B — down 10% from $88.7B a quarter earlier.
Sellers outnumbered buyers: 188 funds closed out of ELV and 142 opened new positions — a net loss of 46 holders — while 607 trimmed existing stakes and 598 added.
The largest buyer was GQG Partners, opening a new position worth an estimated $589M. The largest seller was EdgePoint Investment Group, exiting entirely with an estimated $563M sold.
- 1,589 institutional investors held Elevance Health (ELV) as of Q2 2025, down from 1,660 in Q1 2025.
- Funds reported $79.7B of Elevance Health stock for Q2 2025, down 10% quarter-over-quarter.
- 142 funds opened new Elevance Health positions in Q2 2025 and 188 closed out, a net change of -46 holders.
- The largest Elevance Health buyer in Q2 2025 was GQG Partners, an estimated $589M added.
- The largest Elevance Health seller in Q2 2025 was EdgePoint Investment Group, an estimated $563M sold.
Based on aggregated 13F filings for Q2 2025.